Zai Lab Limited (HKG:9688)
14.36
+0.80 (5.90%)
Jun 18, 2026, 4:08 PM HKT
Zai Lab Market Cap
Zai Lab has a market cap or net worth of 15.74 billion as of June 18, 2026. Its market cap has decreased by -40.69% in one year.
Market Cap
15.74B
Enterprise Value
12.38B
Revenue
3.55B
Ranking
n/a
PE Ratio
n/a
Stock Price
14.36
Market Cap Chart
Since September 18, 2017, Zai Lab's market cap has increased from 1.36B to 15.74B, an increase of 1,058.45%. That is a compound annual growth rate of 32.32%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 16, 2026 | 15.61B | 2.19% |
| Dec 31, 2025 | 15.27B | -31.09% |
| Dec 31, 2024 | 22.16B | 5.54% |
| Dec 29, 2023 | 21.00B | -8.60% |
| Dec 30, 2022 | 22.97B | -51.38% |
| Dec 31, 2021 | 47.25B | -48.85% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Sep 18, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| InnoCare Pharma | 21.72B |
| Metis TechBio | 16.75B |
| Keymed Biosciences | 16.47B |
| Duality Biotherapeutics | 16.20B |
| TenNor Therapeutics (Suzhou) | 13.30B |
| Ascentage Pharma Group International | 11.75B |
| TransThera Sciences (Nanjing) | 11.51B |
| Nanjing Leads Biolabs | 10.66B |